Cargando…

Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo

BACKGROUND: Reducing morbidity is the main target of schistosomiasis control efforts, yet only rarely do control programmes assess morbidity linked to Schistosoma sp. infection. In the Democratic Republic of Congo (DRC), and particularly in north-eastern Ituri Province, little is known about morbidi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nigo, Maurice M., Odermatt, Peter, Nigo, David Wully, Salieb-Beugelaar, Georgette B., Battegay, Manuel, Hunziker, Patrick R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638987/
https://www.ncbi.nlm.nih.gov/pubmed/34855763
http://dx.doi.org/10.1371/journal.pntd.0009375
_version_ 1784609056678215680
author Nigo, Maurice M.
Odermatt, Peter
Nigo, David Wully
Salieb-Beugelaar, Georgette B.
Battegay, Manuel
Hunziker, Patrick R.
author_facet Nigo, Maurice M.
Odermatt, Peter
Nigo, David Wully
Salieb-Beugelaar, Georgette B.
Battegay, Manuel
Hunziker, Patrick R.
author_sort Nigo, Maurice M.
collection PubMed
description BACKGROUND: Reducing morbidity is the main target of schistosomiasis control efforts, yet only rarely do control programmes assess morbidity linked to Schistosoma sp. infection. In the Democratic Republic of Congo (DRC), and particularly in north-eastern Ituri Province, little is known about morbidity associated with Schistosoma mansoni infection. For this reason, we aimed to assess intestinal and hepatosplenic morbidity associated with S. mansoni infection in Ituri Province. METHODS/PRINCIPAL FINDINGS: In 2017, we conducted a cross-sectional study in 13 villages in Ituri Province, DRC. S. mansoni infection was assessed with a Kato-Katz stool test (2 smears) and a point-of-care circulating cathodic antigen (POC-CCA) urine test. A questionnaire was used to obtain demographic data and information about experienced intestinal morbidity. Each participant underwent an abdominal ultrasonography examination to diagnose hepatosplenic morbidity. Of the 586 study participants, 76.6% tested positive for S. mansoni. Intestinal morbidity reported in the two preceding weeks was very frequent, and included abdominal pain (52.7%), diarrhoea (23.4%) and blood in the stool (21.5%). Hepatosplenic morbidity consisted of abnormal liver parenchyma patterns (42.8%), hepatomegaly (26.5%) and splenomegaly (25.3%). Liver pathology (adjusted odds ratio [aOR] 1.20, 95% confidence interval [CI] 1.06–1.37, p = 0.005) was positively and significantly associated with S. mansoni infection. Hepatomegaly (aOR 1.52, 95% CI 0.99–2.32, p = 0.053) and splenomegaly (aOR 1.12, 95% CI 0.73–1.72, p = 0.619) were positively but not significantly associated with S. mansoni infection at the individual level. At the village level, S. mansoni prevalence was positively associated with the prevalence of hepatomegaly and splenomegaly. High-intensity S. mansoni infections were associated with diarrhoea, blood in the stool, hepatomegaly, splenomegaly, and liver parenchyma (C, D, E and F pathology patterns). Four study participants were diagnosed with ascites and five reported hematemesis. CONCLUSIONS/SIGNIFICANCE: Our study documents a high burden of intestinal and hepatosplenic morbidity associated with S. mansoni infection status in Ituri Province. The findings call for targeted interventions to address both S. mansoni infection and related morbidity.
format Online
Article
Text
id pubmed-8638987
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-86389872021-12-03 Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo Nigo, Maurice M. Odermatt, Peter Nigo, David Wully Salieb-Beugelaar, Georgette B. Battegay, Manuel Hunziker, Patrick R. PLoS Negl Trop Dis Research Article BACKGROUND: Reducing morbidity is the main target of schistosomiasis control efforts, yet only rarely do control programmes assess morbidity linked to Schistosoma sp. infection. In the Democratic Republic of Congo (DRC), and particularly in north-eastern Ituri Province, little is known about morbidity associated with Schistosoma mansoni infection. For this reason, we aimed to assess intestinal and hepatosplenic morbidity associated with S. mansoni infection in Ituri Province. METHODS/PRINCIPAL FINDINGS: In 2017, we conducted a cross-sectional study in 13 villages in Ituri Province, DRC. S. mansoni infection was assessed with a Kato-Katz stool test (2 smears) and a point-of-care circulating cathodic antigen (POC-CCA) urine test. A questionnaire was used to obtain demographic data and information about experienced intestinal morbidity. Each participant underwent an abdominal ultrasonography examination to diagnose hepatosplenic morbidity. Of the 586 study participants, 76.6% tested positive for S. mansoni. Intestinal morbidity reported in the two preceding weeks was very frequent, and included abdominal pain (52.7%), diarrhoea (23.4%) and blood in the stool (21.5%). Hepatosplenic morbidity consisted of abnormal liver parenchyma patterns (42.8%), hepatomegaly (26.5%) and splenomegaly (25.3%). Liver pathology (adjusted odds ratio [aOR] 1.20, 95% confidence interval [CI] 1.06–1.37, p = 0.005) was positively and significantly associated with S. mansoni infection. Hepatomegaly (aOR 1.52, 95% CI 0.99–2.32, p = 0.053) and splenomegaly (aOR 1.12, 95% CI 0.73–1.72, p = 0.619) were positively but not significantly associated with S. mansoni infection at the individual level. At the village level, S. mansoni prevalence was positively associated with the prevalence of hepatomegaly and splenomegaly. High-intensity S. mansoni infections were associated with diarrhoea, blood in the stool, hepatomegaly, splenomegaly, and liver parenchyma (C, D, E and F pathology patterns). Four study participants were diagnosed with ascites and five reported hematemesis. CONCLUSIONS/SIGNIFICANCE: Our study documents a high burden of intestinal and hepatosplenic morbidity associated with S. mansoni infection status in Ituri Province. The findings call for targeted interventions to address both S. mansoni infection and related morbidity. Public Library of Science 2021-12-02 /pmc/articles/PMC8638987/ /pubmed/34855763 http://dx.doi.org/10.1371/journal.pntd.0009375 Text en © 2021 Nigo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Nigo, Maurice M.
Odermatt, Peter
Nigo, David Wully
Salieb-Beugelaar, Georgette B.
Battegay, Manuel
Hunziker, Patrick R.
Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo
title Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo
title_full Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo
title_fullStr Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo
title_full_unstemmed Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo
title_short Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo
title_sort morbidity associated with schistosoma mansoni infection in north-eastern democratic republic of the congo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638987/
https://www.ncbi.nlm.nih.gov/pubmed/34855763
http://dx.doi.org/10.1371/journal.pntd.0009375
work_keys_str_mv AT nigomauricem morbidityassociatedwithschistosomamansoniinfectioninnortheasterndemocraticrepublicofthecongo
AT odermattpeter morbidityassociatedwithschistosomamansoniinfectioninnortheasterndemocraticrepublicofthecongo
AT nigodavidwully morbidityassociatedwithschistosomamansoniinfectioninnortheasterndemocraticrepublicofthecongo
AT saliebbeugelaargeorgetteb morbidityassociatedwithschistosomamansoniinfectioninnortheasterndemocraticrepublicofthecongo
AT battegaymanuel morbidityassociatedwithschistosomamansoniinfectioninnortheasterndemocraticrepublicofthecongo
AT hunzikerpatrickr morbidityassociatedwithschistosomamansoniinfectioninnortheasterndemocraticrepublicofthecongo